147 related articles for article (PubMed ID: 15890409)
1. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations.
Pocernich CB; Sultana R; Mohmmad-Abdul H; Nath A; Butterfield DA
Brain Res Brain Res Rev; 2005 Dec; 50(1):14-26. PubMed ID: 15890409
[TBL] [Abstract][Full Text] [Related]
2. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.
Pocernich CB; Sultana R; Hone E; Turchan J; Martins RN; Calabrese V; Nath A; Butterfield DA
J Neurosci Res; 2004 Aug; 77(4):532-9. PubMed ID: 15264223
[TBL] [Abstract][Full Text] [Related]
3. Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.
Turchan-Cholewo J; Liu Y; Gartner S; Reid R; Jie C; Peng X; Chen KC; Chauhan A; Haughey N; Cutler R; Mattson MP; Pardo C; Conant K; Sacktor N; McArthur JC; Hauser KF; Gairola C; Nath A
Neurobiol Dis; 2006 Jul; 23(1):109-19. PubMed ID: 16697650
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
Price TO; Ercal N; Nakaoke R; Banks WA
Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
[TBL] [Abstract][Full Text] [Related]
5. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.
Price TO; Uras F; Banks WA; Ercal N
Exp Neurol; 2006 Sep; 201(1):193-202. PubMed ID: 16750528
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction.
Theodore S; Cass WA; Nath A; Steiner J; Young K; Maragos WF
Neurobiol Dis; 2006 Sep; 23(3):663-8. PubMed ID: 16828290
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
8. Cell death in HIV dementia.
Mattson MP; Haughey NJ; Nath A
Cell Death Differ; 2005 Aug; 12 Suppl 1():893-904. PubMed ID: 15761472
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 Tat neurotoxicity: a model of acute and chronic exposure, and neuroprotection by gene delivery of antioxidant enzymes.
Agrawal L; Louboutin JP; Reyes BA; Van Bockstaele EJ; Strayer DS
Neurobiol Dis; 2012 Feb; 45(2):657-70. PubMed ID: 22036626
[TBL] [Abstract][Full Text] [Related]
10. Sulfated polymannuroguluronate, a novel anti-acquired immune deficiency syndrome drug candidate, decreased vulnerability of PC12 cells to human immunodeficiency virus tat protein through attenuating calcium overload.
Hui B; Li J; Geng MY
J Neurosci Res; 2008 Apr; 86(5):1169-77. PubMed ID: 18092356
[TBL] [Abstract][Full Text] [Related]
11. The multiple roles of p53 in the pathogenesis of HIV associated dementia.
Garden GA; Morrison RS
Biochem Biophys Res Commun; 2005 Jun; 331(3):799-809. PubMed ID: 15865935
[TBL] [Abstract][Full Text] [Related]
12. A review of HIV-1 Tat protein biological effects.
Pugliese A; Vidotto V; Beltramo T; Petrini S; Torre D
Cell Biochem Funct; 2005; 23(4):223-7. PubMed ID: 15473004
[TBL] [Abstract][Full Text] [Related]
13. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia.
Shi B; Raina J; Lorenzo A; Busciglio J; Gabuzda D
J Neurovirol; 1998 Jun; 4(3):281-90. PubMed ID: 9639071
[TBL] [Abstract][Full Text] [Related]
14. Protecting neurons from HIV-1 gp120-induced oxidant stress using both localized intracerebral and generalized intraventricular administration of antioxidant enzymes delivered by SV40-derived vectors.
Louboutin JP; Agrawal L; Reyes BA; Van Bockstaele EJ; Strayer DS
Gene Ther; 2007 Dec; 14(23):1650-61. PubMed ID: 17914406
[TBL] [Abstract][Full Text] [Related]
15. Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif.
Mishra M; Vetrivel S; Siddappa NB; Ranga U; Seth P
Ann Neurol; 2008 Mar; 63(3):366-76. PubMed ID: 18074388
[TBL] [Abstract][Full Text] [Related]
16. MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.
Eldeen MB; Deshmane SL; Simbiri K; Khalili K; Amini S; Sawaya BE
J Neuroimmunol; 2006 Jul; 176(1-2):174-80. PubMed ID: 16750572
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress and therapeutic approaches in HIV dementia.
Steiner J; Haughey N; Li W; Venkatesan A; Anderson C; Reid R; Malpica T; Pocernich C; Butterfield DA; Nath A
Antioxid Redox Signal; 2006; 8(11-12):2089-100. PubMed ID: 17034352
[TBL] [Abstract][Full Text] [Related]
19. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat.
Arp J; Rieder MJ; Urquhart B; Freeman D; Tucker MJ; Krizova A; Lehmann D; Dekaban GA
J Pharmacol Exp Ther; 2005 Sep; 314(3):1218-25. PubMed ID: 15933158
[TBL] [Abstract][Full Text] [Related]
20. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
